NanoDiagnostics Incorporated (NanoDX) has continued to have challenges with releasing their
SARS-CoV-2 detection system. This has slowed progress towards volume production.
Notwithstanding, Sensera has been asked to start the ramp of sensors in Q1 of FY22. ....
More waiting....
I don't think the market will be particularly overjoyed.